Biomarker analysis in patients with steroid-refractory/dependent chronic graft-vs-host disease treated with ruxolitinib or best available therapy in the randomized phase 3 REACH3 study

被引：0
|
作者：
Locatelli, F. [1 ]
Zeiser, R. [2 ]
Teshima, T. [3 ]
Prahallad, A. [4 ]
Sinclair, K. [4 ]
Stefanelli, T. [4 ]
Lee, S. J. [5 ]
机构：
[1] Sapienza Univ Rome, IRCCS, Osped Pediat Bambino Gesu, Rome, Italy
[2] Univ Freiburg, Freiburg, Germany
[3] Hokkaido Univ, Fac Med, Sapporo, Hokkaido, Japan
[4] Novartis Pharma AG, Basel, Switzerland
[5] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O054
引用
收藏
页码：41 / 42
页数：2
相关论文
共 50 条
  • [21] MANAGEMENT OF CORTICOSTEROIDS IN PATIENTS RECEIVING RUXOLITINIB TREATMENT FOR CHRONIC GRAFT-VERSUS-HOST DISEASE: A POST HOC ANALYSIS FROM THE RANDOMIZED PHASE 3 REACH3 STUDY
    Kintsch, Emily
    Xue, Zhenyi
    Galvin, John
    Locatelli, Franco
    Zeiser, Robert
    Bhatt, Valkal
    BONE MARROW TRANSPLANTATION, 2024, 59 : 310 - 310
  • [22] Oral ruxolitinib treatment for patients with ocular manifestations of chronic graft-versus-host disease: a post hoc analysis of the phase 3 REACH3 study
    Sunshine, Sarah
    Bhatt, Valkal
    Galvin, John
    Tian, Chuan
    Zieser, Robert
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [23] Safety Analysis of Patients Who Received Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft-Vs-Host Disease in Expanded Access Programs
    Schroeder, Mark A.
    Toama, Wael
    Fiala, Mark A.
    Naim, Ahmad
    Blithe, Amy
    Paranagama, Dilan
    DiPersio, John F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [24] Results from REACH1, a Single-Arm Phase 2 Study of Ruxolitinib in Combination with Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Vs-Host Disease
    Jagasia, Madan
    Perales, Miguel-Angel
    Schroeder, Mark A.
    Ali, Haris
    Shah, Nirav N.
    Chen, Yi-Bin
    Arbushites, Michael C.
    Dawkins, Fitzroy
    Tian, Chuan
    Khoury, Hanna Jean
    BLOOD, 2018, 132
  • [25] Results From REACH1, a Single-Arm Phase 2 Study of Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Vs-Host Disease
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (03) : 3 - 5
  • [26] Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study
    Zeiser, Robert
    Russo, Domenico
    Ram, Ron
    Hashmi, Shahrukh K.
    Chakraverty, Ronjon
    Middeke, Jan Moritz
    Musso, Maurizio
    Giebel, Sebastian
    Uzay, Ant
    Langmuir, Peter
    Hamad, Nada
    Li, Xuechan
    Gowda, Maanasa
    Stefanelli, Tommaso
    Lee, Stephanie J.
    Teshima, Takanori
    Locatelli, Franco
    BLOOD, 2023, 142
  • [27] Ruxolitinib add-on therapy in steroid-refractory graft-vs-host disease following hematopoietic cell transplantation: A single institutional experience
    Wang, Yi-Lun
    Chang, Tsung-Yen
    Wen, Yu-Chuan
    Yang, Shu-Ho
    Hsiao, Yi-Wen
    Chen, Shih-Hsiang
    Jaing, Tang -Her
    PEDIATRICS AND NEONATOLOGY, 2024, 65 (01): : 85 - 86
  • [28] Early Versus Late Treatment with Ruxolitinib in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease: A Post Hoc Analysis from the Randomized Phase 3 REACH2 Study
    Socie, Gerard
    Xue, Zhenyi
    Bhatt, Valkal
    Galvin, John
    Mohty, Mohamad
    BLOOD, 2022, 140 : 4765 - 4766
  • [29] Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease
    M-A Perales
    N Ishill
    W A Lomazow
    D M Weinstock
    E B Papadopoulos
    H Dastigir
    M Chiu
    F Boulad
    H R Castro-Malaspina
    G Heller
    A A Jakubowski
    R J O'Reilly
    T N Small
    J W Young
    N A Kernan
    Bone Marrow Transplantation, 2007, 40 : 481 - 486
  • [30] Phase I Study of Alemtuzumab for Therapy of Steroid-Refractory Chronic Graft-versus-Host Disease
    Nikiforow, Sarah
    Kim, Haesook T.
    Bindra, Bhavjot
    McDonough, Sean
    Glotzbecker, Brett
    Armand, Philippe
    Koreth, John
    Ho, Vincent T.
    Alyea, Edwin P., III
    Blazar, Bruce R.
    Ritz, Jerome
    Soiffer, Robert J.
    Antin, Joseph H.
    Cutler, Corey S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (05) : 804 - 811
12345